Quest Diagnostics, Inc.’s recently made public that its SVP & General Counsel PREVOZNIK MICHAEL E unloaded Company’s shares for reported $0.71 million on Feb 29 ’24. In the deal valued at $125.88 per share,5,611 shares were sold. As a result of this transaction, PREVOZNIK MICHAEL E now holds 38,478 shares worth roughly $4.95 million.
Then, Doherty Catherine T. sold 1,187 shares, generating $149,420 in total proceeds. Upon selling the shares at $125.88, the EVP, Regional Businesses now owns 68,412 shares.
Before that, Doherty Catherine T. sold 5,557 shares. Quest Diagnostics, Inc. shares valued at $703,349 were divested by the EVP, Regional Businesses at a price of $126.57 per share. As a result of the transaction, Doherty Catherine T. now holds 69,599 shares, worth roughly $8.95 million.
Leerink Partners initiated its Quest Diagnostics, Inc. [DGX] rating to a Market perform in a research note published on February 26, 2024; the price target was $135. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early February from “a Hold” to “a Buy”. Barclays began covering DGX with “an Equal weight” recommendation on January 03, 2024. BofA Securities revised its rating on December 12, 2023. It rated DGX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc. [NYSE:DGX] saw its stock jump 0.09% to $128.64. Over the last five days, the stock has lost -1.08%. Quest Diagnostics, Inc. shares have fallen nearly -6.70% since the year began. Nevertheless, the stocks have fallen -9.83% over the past one year. While a 52-week high of $148.62 was reached on 01/02/24, a 52-week low of $119.59 was recorded on 02/01/24. SMA at 50 days reached $128.12, while 200 days put it at $131.58. A total of 0.7 million shares were traded, compared to the trading of 0.72 million shares in the previous session.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 127.85, which if violated will result in even more drops to 127.05. On the upside, there is a resistance level at 129.66. A further resistance level may holdings at 130.68. The Relative Strength Index (RSI) on the 14-day chart is 45.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.33%. Stochastics %K at 12.71% indicates the stock is a buying.
The most recent change occurred on June 29, 2023 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating .
